Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SELFPOCNAD

Financiado

Cerrado

SelfPOCNAD Development of a Point of Care Detection Device and Self Sampli...

SelfPOCNAD Development of a Point of Care Detection Device and Self Sampling Device for Cervical Cancer Screening Our project is to develop a commercial pre-production prototype point of care test for invasive cervical cancer (ICC). This easy-to-use lab-on-a-chip system (SelfPOCNAD) will enable women to collect samples in the comfort of their... ver más

31/12/2015

NorChip

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

NORCHIP AS No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-12-31 No tenemos la información de la convocatoria

0% 55% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

NorChip

391.40K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CHILI A Community based HPV screening implementation in Low Income... 3M€ Cerrado

MIMICS MicroRNA Isoforms for Molecular Interception of Cervical can... 150K€ Cerrado

VALPAS VALidation of human PApilloma virus assays on Self collected... 71K€ Cerrado

HPV OncoPredict A Groundbreaking Stand Alone Diagnostic Kit to Predict Human... 3M€ Cerrado

VALID-SCREEN Validation of PreCursor M for enhanced Cervical Pre Cancer... 3M€ Cerrado

HoloCyt A rapid low cost cervical cancer screening platform 71K€ Cerrado

Líder del proyecto

NORCHIP AS No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Our project is to develop a commercial pre-production prototype point of care test for invasive cervical cancer (ICC). This easy-to-use lab-on-a-chip system (SelfPOCNAD) will enable women to collect samples in the comfort of their own homes and take them into a GP surgery for testing and provision of immediate results. This will dramatically increase compliance of women with the ICC screening programs will and drastically decrease the ICC incidence and save lives. ICC is the second most common cancer in women. Each year, there are over 470,000 new cases globally. Of these, 33,000 are in the EU. Once the disease is established, it is hard to cure, so each year 233,000 women die - 15,000 in the EU[1]. After breast cancer, it is the second-most-common cancer amongst women. However, this is a preventable and treatable disease, if detected in the early stages. Some EU member states have well-organised screening and effective prevention programmes. But better compliance with screening using this inexpensive lab-on-a-chip system, especially in New Member States, could save the lives of 3-5,000 European women p.a. This demonstration project will enable the SelfPOCNAD consortium to prove that they have a technological and commercially sound proposition. It will allow them to secure investment by either a major blue chip company or an investment house to fund the scale up to production of this life saving and commercially attractive Point of Care (POC) test.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores